Human Longevity doesn’t aim to extend human life so much as to help keep people healthy as they get older.
Dr. Robert Hariri, who once worked directing cell therapy operations at Celgene, a biopharmaceutical company is teaming up with Craig Venter, and engineer Dr. Peter Diamandis, chairman of the X Prize Foundation. Karen Nelson, who headed the J. Craig Venter Institute (JCVI), will lead the microbiome team. They launched a new company called Human Longevity Inc.













